Potential Therapeutic Benefit of C1-Esterase Inhibitor in Neuromyelitis Optica Evaluated In Vitro and in an Experimental Rat Model

Open Access

Peer-reviewed

Research Article

Lukmanee Tradtrantip,

Affiliation Departments of Medicine and Physiology, University of California San Francisco, San Francisco, California, United States of America
⨯
Nithi Asavapanumas,

Affiliation Departments of Medicine and Physiology, University of California San Francisco, San Francisco, California, United States of America
⨯
Puay-Wah Phuan,

Affiliation Departments of Medicine and Physiology, University of California San Francisco, San Francisco, California, United States of America
⨯
A. S. Verkman

* E-mail: Alan.Verkman@ucsf.edu

Affiliation Departments of Medicine and Physiology, University of California San Francisco, San Francisco, California, United States of America
⨯

Reader Comments (0)

Complement inhibitors
Is the Subject Area "Complement inhibitors" applicable to this article?

Thanks for your feedback.
Complement system
Is the Subject Area "Complement system" applicable to this article?

Thanks for your feedback.
Myelitis
Is the Subject Area "Myelitis" applicable to this article?

Thanks for your feedback.
Cytotoxicity
Is the Subject Area "Cytotoxicity" applicable to this article?

Thanks for your feedback.
Heparin
Is the Subject Area "Heparin" applicable to this article?

Thanks for your feedback.
Macromolecules
Is the Subject Area "Macromolecules" applicable to this article?

Thanks for your feedback.
Complement activation
Is the Subject Area "Complement activation" applicable to this article?

Thanks for your feedback.
Astrocytes
Is the Subject Area "Astrocytes" applicable to this article?

Thanks for your feedback.